Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
Clinical trial NCT07366658 · RECRUITING
Trial details
- NCT number
- NCT07366658
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2026-10-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.